Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2011-04-09 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
2011年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement from the company's 2011 first extraordinary general meeting of shareholders. It details the meeting attendance, voting results on various proposals including a non-public issuance of A shares, share issuance plans, and board changes such as the appointment of an independent director. The document includes voting outcomes and legal opinions confirming the meeting's validity. It is a formal announcement of the voting results from a shareholders' meeting rather than the meeting materials or the full report itself. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length and content confirm it is not a brief report publication announcement or a regulatory filing. Confidence is high due to the clear presence of voting results and meeting resolutions.
2011-04-09 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding abnormal stock price fluctuations for the company ST Zhongyuan. It discusses stock price limits being hit on specific dates and confirms that no undisclosed material information exists beyond a previously disclosed non-public stock issuance plan. The document is a regulatory disclosure about stock trading activity and company information status, not a financial report, earnings release, or management discussion. It is a typical regulatory filing to inform investors about stock price movements and company disclosures, fitting the category of Regulatory Filings (RNS). The document length is short and it does not contain financial statements or detailed analysis, so it is not an Annual Report, Interim Report, or Earnings Release. Therefore, the appropriate classification is Regulatory Filings (RNS).
2011-04-08 Chinese
关于召开2011年第一次临时股东大会的再次通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about convening the 2011 first extraordinary general meeting of shareholders for the company. It includes information about the meeting time, location, agenda items to be voted on, voting procedures (including online voting), registration details, and a proxy authorization form. The content is focused on informing shareholders about the meeting and how to participate and vote on specific proposals, including a non-public issuance of A shares and related contracts. There are no financial statements, audit opinions, or management discussions of financial results. The document is not a report itself but a formal announcement and notification about the shareholder meeting and voting process. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings.
2011-04-06 Chinese
2011年第一次临时股东大会会议资料
Capital/Financing Update Classification · 95% confidence The document is a detailed set of materials for a 2011 first extraordinary general meeting (EGM) of shareholders of a company named 中源协和干细胞生物工程股份公司. It includes the meeting agenda, detailed proposals for non-public issuance of A shares, background and purpose of the issuance, information about the investor, financial summaries, and investment project feasibility analysis. The content is focused on capital raising through a non-public share issuance, including specifics on share type, pricing, quantity, use of proceeds, and related corporate actions such as acquisition of a subsidiary. The document is lengthy (15,000 characters) and contains substantive financial and corporate information related to capital raising and financing activities. It is not a simple announcement or a brief summary, nor is it a transcript, audit report, or management report. The primary focus is on the capital/financing update and the non-public share issuance plan. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2011-04-06 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding abnormal stock price fluctuations for the company ST Zhongyuan. It discusses stock price movements over specific dates, inquiries made to controlling shareholders and management, and confirms no undisclosed material information exists beyond a previously disclosed non-public stock issuance plan. The document is a regulatory disclosure about stock trading activity and company information status, not a financial report, earnings release, or management discussion. It is not a report publication announcement since it contains substantive content about stock trading irregularities and company statements. This fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2011-03-30 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding abnormal stock price fluctuations over three consecutive trading days. It includes statements from the company's board confirming no undisclosed material information beyond a previously disclosed non-public stock issuance plan. The document serves as a regulatory disclosure to inform investors about stock trading anomalies and related company confirmations. It does not contain financial statements, audit information, or detailed financial results. It is not a report or presentation but a regulatory announcement about stock trading activity and company disclosures. Therefore, it fits best under Regulatory Filings (RNS). The document length is short and focused on compliance disclosure rather than a full report.
2011-03-24 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.